Recombinant Macaca fascicularis C-C chemokine receptor type 5 (CCR5) is a laboratory-engineered protein produced by cloning and expressing the CCR5 gene from cynomolgus macaques in heterologous systems such as E. coli. CCR5 is a G protein-coupled receptor (GPCR) with seven transmembrane domains, critical for immune cell migration and activation. In macaques, it serves as a primary co-receptor for simian immunodeficiency virus (SIV), making it a pivotal model for studying HIV pathogenesis and therapeutic interventions .
Domains:
SIV/HIV Entry Mechanism: Recombinant CCR5 enables structural studies of SIV gp120 binding and viral membrane fusion .
Co-receptor Function: CCR5 facilitates SIVmac251 entry into macrophages and T cells, mirroring HIV-1 infection in humans .
CCR5 Inhibitors: Small molecules like CMPD 167 suppress SIV replication in macaques by blocking CCR5 .
Gene Therapy: CRISPR-Cas9-mediated CCR5 disruption in hematopoietic stem cells reduced SIV infection in macaques .
Vaccines targeting CCR5 extracellular domains induced anti-CCR5 antibodies, suppressing SIVmac251 viremia in 25% of vaccinated macaques .
CCR5 Inhibition: Treatment with CCR5 antagonists reduced SIV viral loads by 50-fold in macaques, though transient CXCR4-tropic virus surges occurred .
Vaccine Efficacy: Anti-CCR5 antibodies correlated with undetectable SIV RNA in 25% of vaccinated macaques post-challenge .
Gene Editing: CCR5-disrupted HSPCs reduced SIV infection by 5–15% in autografted macaques .
This receptor binds various inflammatory CC-chemokines, including CCL3/MIP-1α, CCL4/MIP-1β, and RANTES. Binding initiates intracellular signaling by increasing calcium ion levels. CCR5 may regulate granulocytic lineage proliferation or differentiation and facilitates T-lymphocyte migration to infection sites by acting as a chemotactic receptor.
KEGG: mcf:102139456
UniGene: Mfa.5900
CCR5 in Mauritian cynomolgus macaques (MCM, Macaca fascicularis) serves as a co-receptor for simian immunodeficiency virus (SIV) and HIV entry into cells, similar to its function in humans. The receptor is primarily expressed on leukocytes and plays pivotal roles in inflammatory responses and immune function . A 24-bp region in the macaque CCR5 gene has been identified as essential for its expression . Unlike humans, naturally occurring CCR5 mutations conferring HIV resistance are not documented in macaques, making them valuable models for studying genome editing approaches to HIV resistance .
While the search results don't provide specific structural comparisons, research indicates functional homology between macaque and human CCR5. The essential regions for CCR5 expression in macaques have been identified, including a critical 24-bp region that researchers target when attempting to functionally delete CCR5 in these animals . This functional similarity makes macaques suitable models for studying HIV co-receptor interactions, despite potential structural differences. Researchers have successfully applied human CCR5-targeting strategies to macaque models, suggesting substantial conservation of critical functional domains .
Researchers typically isolate genomic DNA from macaque peripheral blood mononuclear cells using commercial kits such as Quick-DNA Miniprep (Zymo Research) . For recombinant expression, several approaches have been documented:
PCR amplification of the CCR5 gene using primers flanking the coding region
Cloning into expression vectors suited for mammalian cell expression
Transfection into cell lines such as HEK293T for functional studies
For quality control, researchers verify CCR5 expression through:
PCR amplification with primers that generate either short (613 bp) or long (2,925 bp) amplicons
Gel electrophoresis to visualize amplicons (1.2%-1.5% agarose gels at 120V)
DNA sequencing to confirm the integrity of the expressed gene
Successful CRISPR-Cas9 editing of CCR5 in Mauritian cynomolgus macaques has been achieved using a dual-guide approach. Researchers design guide RNAs to encompass a 24-bp deletion essential for CCR5 expression in non-human primates . The specific methodology includes:
Design of guide RNAs targeting conserved regions of the CCR5 gene
Microinjection of CRISPR-Cas9 components (Cas9 protein and gRNAs) into one-cell stage embryos
Cultivation of embryos to blastocyst stage
PCR-based screening and whole genome sequencing to evaluate editing outcomes
Using this approach, researchers have achieved biallelic deletions in approximately 23-37% of MCM embryos . The dual-guide strategy targets two specific sites within the CCR5 gene to create a deletion that functionally inactivates the receptor, mimicking the protective effect seen with CCR5Δ32 in humans .
Comprehensive verification of CRISPR-Cas9 editing outcomes in CCR5-edited macaque models requires a multi-layered approach:
On-target verification:
PCR amplification with primers flanking the target region (yielding 613 bp for wild-type and 415 bp for biallelic deletion mutants)
Long-range PCR (2,925 bp amplicon) to detect large-scale deletions near the target site
Gel electrophoresis to visualize amplicons
Single-cell whole genome sequencing (WGS) to detect mosaicism and structural variants
Off-target analysis:
Computational prediction of potential off-target sites using tools like Cas-OFFinder (allowing for three mismatches)
WGS comparison between edited cells/embryos and parental DNA
Sanger sequencing of PCR amplicons from predicted off-target regions
Identification of de novo structural variants and single nucleotide variants not present in parental DNA
Research has revealed that PCR-based methods alone may underestimate the complexity of editing outcomes, as WGS has identified large-scale deletions (up to ~5.2 kb) and inversions that contribute to greater mosaicism than initially detected .
Mosaicism is a significant consideration in CRISPR-Cas9-edited macaque embryos. Single blastomere PCR analysis has revealed substantial mosaicism within individual embryos . Whole genome sequencing has further demonstrated that mosaicism is more prevalent than initially detected by PCR-based methods alone .
Specific findings on mosaicism include:
Varied editing outcomes between blastomeres from the same embryo
De novo structural variants unique to specific blastomeres
Different large-scale deletions (ranging from the precise target deletion to ~5.2 kb deletions) in different cells of the same embryo
This mosaicism presents challenges for developing models with consistent genotypes and must be carefully considered when interpreting phenotypic results from genome-edited animals.
The human CCR5Δ32 mutation confers resistance to HIV-1 infection, and transplantation of hematopoietic stem cells (HSCs) containing this mutation to HIV patients has led to HIV cure in some cases . Researchers aim to mimic this resistance through genetic editing of CCR5 in macaque models.
Key comparisons:
Target region: While human CCR5Δ32 is a specific 32-bp deletion, macaque studies target a 24-bp region essential for CCR5 expression in non-human primates
Efficiency: CRISPR-Cas9 editing has achieved biallelic deletions in ~23-37% of MCM embryos , whereas CCR5Δ32 occurs naturally in certain human populations
Functional outcome: Both approaches aim to disrupt CCR5 function as an HIV co-receptor, though through different specific mutations
Consistency: The human CCR5Δ32 is a defined mutation, while CRISPR-Cas9 editing can produce diverse outcomes, including large-scale deletions and mosaicism
The development of CCR5-edited macaque models provides a platform to determine mechanisms of HIV elimination following HSC transplantation and to develop clinical protocols for reproducible HIV cure .
Evaluation of SIV resistance in CCR5-modified macaques utilizes several methodological approaches:
Viral challenge studies: Exposing edited animals to SIV and monitoring for infection
Viral load monitoring: Quantitative measurement of plasma viral RNA
Replication-competent viral reservoir (RCVR) analysis: Using statistical tools to calculate the size of the viral reservoir based on viral load and viral outgrowth data
CD4+ T cell counts: Monitoring immune cell populations susceptible to SIV infection
Antibody response analysis: Measuring the development of anti-SIV antibodies
Time to viral rebound: After antiretroviral therapy interruption, measuring the time until viral loads become detectable again
Research has shown that CCR5-targeted treatments in macaques result in smaller RCVR sizes compared to control animals (p=0.01 and p=0.0002), demonstrating the effectiveness of these interventions .
Whole genome sequencing of CRISPR-Cas9-edited CCR5 in MCM embryos has revealed several types of large-scale chromosomal anomalies:
| Blastomere | Structural Variant Type | Size | Position |
|---|---|---|---|
| 4-6 | Deletion | 22,471 bp | chr9:124,893,068-124,915,539 |
| 5-4 | Deletion | 6,532 bp | chr9:124,899,468-124,906,000 |
| 5-5 | Deletion | 5,244 bp | chr9:124,900,756-124,906,000 |
| 5-8 | Deletion | 5,247 bp | chr9:124,900,753-124,906,000 |
| 4-1, 4-5 | Inversion | 219 bp | chr9:124,899,798-124,900,017 |
| 5-1, 5-2 | Inversion | 3,019 bp | chr9:124,897,701-124,900,720 |
Additionally, homozygous insertions of 13 bp, 5 bp, 11 bp, and 33 bp were identified near one gRNA cut site in blastomere 5-4 .
These findings align with observations in other species, where CRISPR-Cas9 editing has resulted in unintended chromosomal anomalies, including large deletions and loss of heterozygosity. Such anomalies could potentially impact embryo viability and necessitate careful screening when developing edited animal models .
Successful genome editing in MCM embryos requires optimized protocols for ovarian stimulation, in vitro fertilization, and embryo culture. Key optimization strategies include:
Ovarian stimulation protocol adaptation:
CRISPR-Cas9 microinjection timing:
Embryo culture optimization:
Quality control measures:
These optimizations are essential for generating viable CCR5-edited embryos and ultimately establishing CCR5-mutant MCM models for HIV/SIV research.
Detecting subtle off-target effects requires sophisticated analytical approaches:
Computational prediction and prioritization:
Whole genome sequencing analysis:
Single-cell sequencing approaches:
Multi-caller validation:
PCR validation of predicted off-target sites:
This multi-layered approach allows for comprehensive detection of both predicted and unexpected off-target effects that might impact model development and experimental interpretation.
CCR5-edited macaque models provide critical insights for translational HIV cure research:
Evaluating HSC transplantation strategies:
Optimizing clinical protocols:
Addressing physiological relevance:
Comparing intervention strategies:
These models bridge the gap between basic HIV research and clinical applications, potentially accelerating the development of curative interventions for HIV infection.
Research with CCR5-edited macaque models has identified several safety considerations crucial for clinical translation:
Chromosomal instability:
Off-target mutations:
Mosaicism:
Functional consequences:
CCR5 plays roles beyond HIV co-receptor function
Potential immunological impacts of CCR5 modification require evaluation
These findings suggest that further optimization of macaque embryo editing to avoid targeting errors would be essential for both model development and eventual clinical translation . Comprehensive genomic analysis beyond PCR-based methods is necessary to fully characterize editing outcomes.
Future improvements in CCR5 editing specificity may come from several technological advances:
Base editing technologies:
Precise C-to-T or A-to-G conversions without double-strand breaks
Potentially reduced large-scale chromosomal anomalies
Prime editing:
Programmable "search-and-replace" editing offering precise modifications
Reduced off-target effects compared to conventional CRISPR-Cas9
High-fidelity Cas9 variants:
Engineered Cas9 proteins with reduced off-target activity
Application of SpCas9-HF1, eSpCas9, or HypaCas9 variants
Alternative delivery methods:
Ribonucleoprotein (RNP) delivery to reduce editing duration and off-target effects
Timing optimization to minimize mosaicism
Improved computational prediction:
Enhanced algorithms for off-target prediction
Integration of chromatin accessibility data to predict actual off-target likelihood
These advances may address the current limitations of CRISPR-Cas9 editing in macaque embryos, including large-scale deletions, inversions, and mosaicism .
Emerging analytical techniques that could improve detection of CCR5 editing outcomes include:
Long-read sequencing:
Digital droplet PCR:
Improved quantification of editing efficiency
Enhanced sensitivity for detecting low-frequency edits
Single-cell multi-omics:
Integrated analysis of genomic and transcriptomic changes
Assessment of functional consequences of CCR5 modification at single-cell resolution
CRISPR-specific sequencing approaches:
DISCOVER-Seq for unbiased off-target detection
GUIDE-Seq or CIRCLE-Seq for comprehensive off-target profiling
Advanced bioinformatic pipelines:
Integration of multiple structural variant callers
Machine learning approaches to distinguish true editing events from sequencing artifacts
These techniques would address the limitations of current methods, where short-read sequencing platforms are "not ideally suited for identifying structural variants" and provide more comprehensive characterization of editing outcomes.